Cardiovascular
Cardiovascular(心血管)
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
- Acute Phase Reactants(17)
- Angina(14)
- Arrhythmia(85)
- Atherosclerosis(93)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(46)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(131)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(10)
- Endothelium(35)
- Erythrocytes & Hemoglobin(53)
- Heart Failure(32)
- Hypertension(167)
- Hypotension(24)
- Lipoproteins(66)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(64)
- Others(53)
- Serum Proteins(11)
- Smooth Muscle Cells(37)
- Storage & Transport(6)
- Stroke(53)
- Vasoconstriction(61)
- Thrombosis(58)
- Vasodilation(146)
Cardiovascular 相关产品(860)
- GC187481a,1b-dihomo Prostaglandin E1CAS: 23452-98-4
Produced from COX metabolism of 10,13,16-docosatrienoic acid
- GC1877716,16-dimethyl Prostaglandin E1CAS: 41692-15-3
A potent inducer of vascular smooth muscle contractions
- GC18837Carbocyclic Thromboxane A2CAS: 74034-56-3
A TXA 2 analog with vasoconstrictor and anti-platelet aggregation activity
- GC19433Cholesteryl HeptadecanoateCAS: 24365-37-5纯度: >97.00%
An internal standard for quantification of cholesterol esters
- GC19437D-NAME (hydrochloride)CAS: 50912-92-0
A less active enantiomer of the NO synthase inhibitor L-NAME
- GC19438TMB 8 (hydrochloride)CAS: 53464-72-5纯度: >98.00%
A non-competitive antagonist of nAChRs and an inhibitor of intracellular calcium availability
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC18634 | 11-deoxy Prostaglandin E1 | 37786-00-8 | >98.00% | |
A selective EP 2 receptor agonist | ||||
| GC18635 | 18-hydroxy-11-deoxy Corticosterone | 379-68-0 | - | |
A mineralocorticoid | ||||
| GC18637 | 11β-Prostaglandin F2α | 38432-87-0 | >98.00% | |
The primary PGD 2 metabolite | ||||
| GC18686 | Prazobind | 107021-36-3 | - | |
An α 1 -adrenergic receptor antagonist | ||||
| GC18698 | CAY10665 | 1235543-17-5 | - | |
A stable bioisostere of the antiarrhythmic 17,18-EET | ||||
| GC18707 | Pimprinine | 13640-26-1 | - | |
An alkaloid with diverse biological activities | ||||
| GC18716 | Bisindolylmaleimide XI (hydrochloride) | 145333-02-4 | - | |
A PKC inhibitor | ||||
| GC18737 | 8-iso Prostaglandin E1 | 21003-46-3 | >98.00% | |
An isoprostane with vasoconstrictor activity | ||||
| GC18748 | 1a,1b-dihomo Prostaglandin E1 | 23452-98-4 | - | |
Produced from COX metabolism of 10,13,16-docosatrienoic acid | ||||
| GC18768 | Prostaglandin E1 ethyl ester | 35900-16-4 | - | |
An esterified form of PGE 1 | ||||
| GC18777 | 16,16-dimethyl Prostaglandin E1 | 41692-15-3 | - | |
A potent inducer of vascular smooth muscle contractions | ||||
| GC18788 | Graphislactone A | 52179-44-9 | - | |
An antioxidant | ||||
| GC18820 | 6-keto Prostaglandin E1 | 67786-53-2 | - | |
A PGI 2 metabolite with vasodilator activity | ||||
| GC18837 | Carbocyclic Thromboxane A2 | 74034-56-3 | - | |
A TXA 2 analog with vasoconstrictor and anti-platelet aggregation activity | ||||
| GC18855 | Prostaglandin A1 ethyl ester | 93464-24-5 | - | |
A prodrug form of PGA 1 | ||||
| GC18879 | CAY10662 | 1184844-74-3 | - | |
A urea derivative of 17(18)-EpETE | ||||
| GC18962 | U-92016A | 149654-41-1 | - | |
A 5-HT 1A receptor agonist | ||||
| GC18999 | Prostaglandin D1 | 17968-82-0 | >98.00% | |
An inhibitor of platelet aggregation | ||||
| GC19433 | Cholesteryl Heptadecanoate | 24365-37-5 | >97.00% | |
An internal standard for quantification of cholesterol esters | ||||
| GC19437 | D-NAME (hydrochloride) | 50912-92-0 | - | |
A less active enantiomer of the NO synthase inhibitor L-NAME | ||||
| GC19438 | TMB 8 (hydrochloride) | 53464-72-5 | >98.00% | |
A non-competitive antagonist of nAChRs and an inhibitor of intracellular calcium availability | ||||
| GC19460 | 9(S)-HODE | 73543-67-6 | >98.00% | |
A lipoxygenase product of linoleic acid | ||||
| GC19530 | Brassicasterol | 474-67-9 | >95.00% | |
A phytosterol | ||||
| GC19686 | DL-Pyroglutamic acid | 149-87-1 | - | |
| ||||